Atracurium Besylate

PreclinicalSmall molecule

MMansoura University

Atracurium Besylate is one of 63 small molecule programs targeting Inguinal hernia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Inguinal HerniaActive, not recruiting

Breast CancerActive, not recruiting

Inguinal HerniaPreclinical

Active, not recruiting

Breast CancerPreclinical

Active, not recruiting

Competition

Competitive Landscape

744 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Lexiscan

Astellas

Preclinical

1 2

Voltaren

Novartis

Preclinical

1 3

Zolymbus

AbbVie

Preclinical

1 4

Blenoxane

Bristol-Myers Squibb

Preclinical

1 5

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

3 6

Methylthioninium Chloride

PProvepharm SAS

Preclinical

3 7

Duragesic-100

CCephalon

Preclinical

2 8

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

2 9

Spravato

WWim Janssens

Preclinical

2 10

Sporanox

SSebela Pharmaceuticals Development LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Anesthesia1 trial

Effect of Atracurium and Rocuronium on the State and Response Entropy During Isoflurane Anesthesia

Completed·—·Phase 1·NCT05097508·40 enrolled

Breast Cancer1 trial

Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery

Withdrawn·TTata Memorial Centre·N/A·NCT03005860

Inguinal hernia1 trial

Quadratus Lumborum Versus Transversus Abdominis Plane Block Versus Caudal Block for Postoperative Analgesia After Pediatric Inguinal Hernia : Double-Blinded Randomized Trial

Unknown status·TTanta University·N/A·NCT05442905·60 enrolled

Hypotensive Anesthesia1 trial

Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation

Unknown status·MMansoura University·N/A·NCT05241054·64 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Atracurium Besylate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Atracurium Besylate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Atracurium Besylate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mansoura University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMansoura University

Atracurium Besylate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Anesthesia1 trial

Breast Cancer1 trial

Inguinal hernia1 trial

Hypotensive Anesthesia1 trial

References

Drug Info

Quick Facts

Related News